These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22832136)

  • 1. Prolongation of idiopathic thrombocytopenic purpura associated with paroxetine administration.
    Ono S; Suzuki Y; Someya T
    Gen Hosp Psychiatry; 2013; 35(2):213.e13-5. PubMed ID: 22832136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SSRIs and ejaculation.
    Robbins A
    J Clin Psychopharmacol; 2003 Feb; 23(1):108; author reply 108-9. PubMed ID: 12544388
    [No Abstract]   [Full Text] [Related]  

  • 3. Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors.
    Eaddy M; Bramley T; Regan T
    Manag Care Interface; 2003 Dec; 16(12):22-7. PubMed ID: 14750459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.
    Polimeni G; Grugno R; Cordici F; Vitetta A; Caputi AP; Bramanti P
    J Clin Psychopharmacol; 2008 Oct; 28(5):589-91. PubMed ID: 18794668
    [No Abstract]   [Full Text] [Related]  

  • 6. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-emetic effect of mosapride citrate hydrate, a 5-HT4 receptor agonist, on selective serotonin reuptake inhibitors (SSRIs)-induced emesis in experimental animals.
    Mine Y; Oku S; Yoshida N
    J Pharmacol Sci; 2013; 121(1):58-66. PubMed ID: 23257657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

  • 9. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
    Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New dosage-reduction regime to avoid paroxetine discontinuation syndrome.
    Pacheco Yáñez L; Malo P; Etxebeste M; Aragües E; Medrano J
    Can J Psychiatry; 2003 Mar; 48(2):129-30. PubMed ID: 12655918
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation.
    Uguz F
    Breastfeed Med; 2019 Mar; 14(2):131-132. PubMed ID: 30489153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction associated with serotonin specific reuptake inhibitors.
    Herrán A; Palacios-Araus L; Vázquez-Barquero JL; Díez-Manrique JF
    J Clin Psychopharmacol; 1997 Feb; 17(1):67-8. PubMed ID: 9004071
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome after addition of paroxetine to olanzapine.
    Kontaxakis VP; Havaki-Kontaxaki BJ; Pappa DA; Katritsis DE; Christodoulou GN
    J Clin Psychopharmacol; 2003 Dec; 23(6):671-2. PubMed ID: 14624202
    [No Abstract]   [Full Text] [Related]  

  • 14. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.
    John AP; Koloth R
    Aust N Z J Psychiatry; 2007 Feb; 41(2):192-3. PubMed ID: 17484083
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors.
    Strachan J; Shepherd J
    Aust N Z J Psychiatry; 1998 Apr; 32(2):295-8. PubMed ID: 9588311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine.
    Coskun M; Adak I; Akaltun I
    J Clin Psychopharmacol; 2014 Aug; 34(4):537-8. PubMed ID: 24949703
    [No Abstract]   [Full Text] [Related]  

  • 18. Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression.
    Kasper S; Gastpar M; Möller HJ; Müller WE; Volz HP; Dienel A; Kieser M
    Int Clin Psychopharmacol; 2010 Jul; 25(4):204-13. PubMed ID: 20568656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of SSRI-induced hyponatremia.
    Corrington KA; Gatlin CC; Fields KB
    J Am Board Fam Pract; 2002; 15(1):63-5. PubMed ID: 11841140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.